The Company’s outstanding warrant liabilities consisted of the following:
December 31, 2013 | ||||||||||||||
Issue Date |
Expiration Date |
Series | Exercise Price per Share |
Shares Issuable upon Exercise |
Fair Value | |||||||||
(in thousands except share and per share data) | ||||||||||||||
October 2012 |
October 2022 | Common | 0.24 | 1,017,227 | $ | 9,624 | ||||||||
November 2012 |
October 2022 | Common | 0.24 | 2,787 | 26 | |||||||||
|
|
|
|
|||||||||||
1,020,014 | $ | 9,650 | ||||||||||||
|
|
|
|
December 31, 2012 | ||||||||||||||||
Issue Date |
Expiration Date | Series | Exercise Price per Share |
Shares Issuable upon Exercise |
Fair Value | |||||||||||
(in thousands except share and per share data) | ||||||||||||||||
Preferred Warrants: |
||||||||||||||||
October 2005 |
October 2015 | Series C | 4.30 | 232,558 | $ | 1 | ||||||||||
October 2005 |
October 2013 | Series C | 4.30 | 8,795 | — | |||||||||||
December 2005 |
December 2013 | Series C | 4.30 | 7,207 | — | |||||||||||
July 2006 |
July 2014 | Series C | 4.30 | 10,930 | — | |||||||||||
October 2006 |
October 2014 | Series C | 4.30 | 2,336 | — | |||||||||||
December 2006 |
December 2014 | Series C | 4.30 | 1,706 | — | |||||||||||
March 2007 |
March 2015 | Series C | 4.30 | 3,052 | — | |||||||||||
June 2007 |
June 2017 | Series C | 4.30 | 2,410 | — | |||||||||||
September 2007 |
September 2017 | Series C | 4.30 | 93,023 | 2 | |||||||||||
August 2008 |
August 2016 | Series D | 5.06 | 2,369 | — | |||||||||||
March 2010 |
March 2020 | Series D-2 | 0.70 | 2,057,142 | 315 | |||||||||||
May 2011 |
May 2021 | Series D-2 | 0.001 | 13,070,398 | 4,040 | |||||||||||
|
|
|
|
|||||||||||||
15,491,926 | 4,358 | |||||||||||||||
|
|
|
|
|||||||||||||
Common Warrants: |
||||||||||||||||
October 2012 |
October 2022 | Common | 0.24 | 1,058,221 | 6,163 | |||||||||||
November 2012 |
October 2022 | Common | 0.24 | 3,324 | 19 | |||||||||||
|
|
|
|
|||||||||||||
1,061,545 | 6,182 | |||||||||||||||
|
|
|
|
|||||||||||||
$ | 10,540 | |||||||||||||||
|
|